Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Total Liabilities (2022 - 2025)

Envoy Medical's Total Liabilities history spans 4 years, with the latest figure at $15.7 million for Q3 2025.

  • For Q3 2025, Total Liabilities fell 43.74% year-over-year to $15.7 million; the TTM value through Sep 2025 reached $15.7 million, down 43.74%, while the annual FY2024 figure was $30.4 million, 202.38% up from the prior year.
  • Total Liabilities for Q3 2025 was $15.7 million at Envoy Medical, down from $39.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $39.8 million in Q2 2025 and bottomed at $10.0 million in Q4 2023.
  • The 4-year median for Total Liabilities is $21.2 million (2023), against an average of $23.9 million.
  • The largest annual shift saw Total Liabilities crashed 74.07% in 2023 before it soared 202.38% in 2024.
  • A 4-year view of Total Liabilities shows it stood at $38.8 million in 2022, then plummeted by 74.07% to $10.0 million in 2023, then skyrocketed by 202.38% to $30.4 million in 2024, then plummeted by 48.28% to $15.7 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Total Liabilities are $15.7 million (Q3 2025), $39.8 million (Q2 2025), and $34.6 million (Q1 2025).